GRAFT VERSUS HOST DISEASE IN EYE

GRAFT VERSUS HOST DISEASE IN EYE was reported 231 times

GRAFT VERSUS HOST DISEASE IN EYE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Mucocutaneous Epithelial Cell Growth Factor [EPC] 1 0.0026
1 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 5 0.0015
2 Echinocandin Antifungal [EPC] 3 0.0004
3 CD22-directed Immunoconjugate [EPC] 1 0.0003
4 Calcineurin Inhibitor Immunosuppressant [EPC] 43 0.0003
5 Sulfone [EPC] 3 0.0003
6 Tetracycline-class Antibacterial [EPC] 2 0.0003
7 Antimetabolite Immunosuppressant [EPC] 5 0.0002
8 Bile Acid [EPC] 5 0.0002
9 Janus Kinase Inhibitor [EPC] 34 0.0002
10 CD52-directed Cytolytic Antibody [EPC] 4 0.0002
11 Alkylating Drug [EPC] 50 0.0002
12 Ergot Derivative [EPC] 1 0.0002
13 CD30-directed Immunoconjugate [EPC] 2 0.0002
14 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 3 0.0002
15 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0001
16 Azole Antifungal [EPC] 20 0.0001
17 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 14 0.0001
18 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 14 0.0001
19 Kinase Inhibitor [EPC] 64 0.0001
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 11 0.0001
21 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
22 Antimalarial [EPC] 1 0.0001
23 Folate Analog Metabolic Inhibitor [EPC] 42 0.0001
24 Antiprotozoal [EPC] 1 0.0001
25 Selective T Cell Costimulation Modulator [EPC] 11 0.0001
26 Topoisomerase Inhibitor [EPC] 6 0.0001
27 Oxazolidinone Antibacterial [EPC] 2 0.0001
28 Corticosteroid [EPC] 79 0.0001
29 Proteasome Inhibitor [EPC] 7 0.0001
30 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
31 CD20-directed Cytolytic Antibody [EPC] 18 0.0001
32 Complement Inhibitor [EPC] 3 0.0001
33 Nucleoside Metabolic Inhibitor [EPC] 14 0.0001
34 Purine Antimetabolite [EPC] 5 0.0001
35 Human Immunoglobulin G [EPC] 1 0.0000
36 Aminoglycoside Antibacterial [EPC] 2 0.0000
37 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1 0.0000
38 Nucleoside Analog Antiviral [EPC] 3 0.0000
39 Leukotriene Receptor Antagonist [EPC] 1 0.0000
40 Iron Chelator [EPC] 1 0.0000
41 BCL-2 Inhibitor [EPC] 2 0.0000
42 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
43 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
44 Arteriolar Vasodilator [EPC] 2 0.0000
45 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
46 Osmotic Laxative [EPC] 7 0.0000
47 Calcium [EPC] 3 0.0000
48 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
49 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
50 Leukocyte Growth Factor [EPC] 2 0.0000
51 Integrin Receptor Antagonist [EPC] 1 0.0000
52 Thalidomide Analog [EPC] 6 0.0000
53 Central Nervous System Stimulant [EPC] 1 0.0000
54 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
55 Expectorant [EPC] 2 0.0000
56 Proton Pump Inhibitor [EPC] 5 0.0000
57 Fluoroquinolone Antibacterial [EPC] 1 0.0000
58 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
59 Opioid Agonist [EPC] 2 0.0000
60 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
61 Platinum-based Drug [EPC] 2 0.0000
62 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
63 alpha-Adrenergic Blocker [EPC] 1 0.0000
64 Insulin Analog [EPC] 3 0.0000
65 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
66 Estrogen [EPC] 1 0.0000
67 Thiazide Diuretic [EPC] 1 0.0000
68 Benzodiazepine [EPC] 3 0.0000
69 Factor Xa Inhibitor [EPC] 1 0.0000
70 beta-Adrenergic Blocker [EPC] 1 0.0000
71 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
72 Vitamin C [EPC] 1 0.0000
73 Loop Diuretic [EPC] 1 0.0000
74 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
75 Platelet Aggregation Inhibitor [EPC] 1 0.0000
76 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000